Serum Level of Soluble CD163 May Be a Predictive Marker of the Effectiveness of Nivolumab in Patients With Advanced Cutaneous Melanoma
暂无分享，去创建一个
Y. Fujisawa | S. Aiba | H. Uchi | A. Otsuka | S. Matsushita | R. Tanaka | M. Aoki | Yuki Yamamoto | H. Hata | T. Fujimura | Y. Kambayashi | A. Hashimoto | N. Wada | T. Hidaka | T. Funakoshi | K. Yoshino | K. Imafuku | Y. Nonomura | K. Tanita | H. Irie | Yota Sato | H. Okuhira